Talk:Novartis
Appearance
This is the talk page for discussing improvements to the Novartis article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Archives: 1Auto-archiving period: 60 days ![]() |
![]() | This ![]() It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||
|
![]() | The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE. |
Animal Health?
[edit]Novartis sold their Animal Health division to Lilly 7 or 8 years ago, Lilly has since spun it off into Elanco. I would edit the page but it would be a conflict of interest; I suggest someone take the initiative upon themselves to do so. CastAStone//(talk) 19:19, 25 February 2021 (UTC)
Categories:
- C-Class vital articles
- Wikipedia level-5 vital articles
- Wikipedia vital articles in Society and social sciences
- C-Class level-5 vital articles
- Wikipedia level-5 vital articles in Society and social sciences
- C-Class vital articles in Society and social sciences
- C-Class company articles
- Top-importance company articles
- WikiProject Companies articles
- C-Class pharmacology articles
- High-importance pharmacology articles
- WikiProject Pharmacology articles
- C-Class Switzerland articles
- High-importance Switzerland articles
- All WikiProject Switzerland pages
- Talk pages of subject pages with paid contributions